Asia Deal Watch: Astellas Expands Protein Degrader R&D Capability With PeptiDream Collaboration

 
• By Joseph Haas, Vibha Ravi, and Lisa Takagi

Plus deals involving Santen/Harrow/Visiox, Aurobindo/BioFactura, AFT/Crossject, Imugene/RenovoRx, Biotheus/BioNTech, GeneQuantum/InxMed, ObsEva/Yuyuan, Monopar/National University of Singapore and Doer Biologics/BioNTech.

Asia Deal Watch
• Source: Alamy

More from Deals

More from Business